Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Diagnostics
MedTech
GE HealthCare's PET agent Vizamyl expands reach in Alzheimer's
The imaging agent can be used to deliver quantitative assessments such as calculations of amyloid prevalence through FDA-authorized software.
Conor Hale
Jun 27, 2025 9:45am
Cosmo to connect Medtronic GI Genius with Apple Vision Pro
Jun 25, 2025 4:00pm
Illumina picks up proteomics developer SomaLogic for $425M
Jun 23, 2025 11:00am
Abbott lines up diabetes collabs for its glucose-ketone sensor
Jun 20, 2025 11:41am
Grail plans to submit updated Galleri blood test to FDA in 2026
Jun 18, 2025 11:45am
Caris Life Sciences ups IPO to raise $494M
Jun 18, 2025 11:00am
